National shareholder rights litigation firm Schall, Brown & Schwartz LLP (“SBS”) has issued a formal reminder to investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding an active securities fraud class action lawsuit. The litigation provides eligible investors who suffered financial losses an opportunity to move the court for appointment as lead plaintiff in the ongoing action.
The lawsuit asserts claims against Hims & Hers Health, Inc. for alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alongside Rule 10b-5 promulgated by the U.S. Securities and Exchange Commission (SEC). These federal statutes govern accountability regarding material misstatements, omissions, and deceptive practices in public securities trading.
ALSO READ | Food Bank for NYC Urges Congress to Halt SNAP Cost Shift and Fully Fund Emergency Aid
According to details released by the law firm, the class action seeks to recover losses sustained by institutional and retail investors who purchased the company's publicly traded securities. Under the Private Securities Litigation Reform Act, qualifying shareholders may apply to represent the class as lead plaintiffs, overseeing the legal proceedings on behalf of all affected market participants.
Schall, Brown & Schwartz LLP operates nationally as a legal practice focused on corporate governance and shareholder rights litigation. The firm regularly initiates and manages class actions aimed at enforcing executive compliance, financial reporting accuracy, and transparency within public capital markets.
Hims & Hers Health, Inc., which trades under the symbol HIMS on the New York Stock Exchange, faces this class action notice as legal proceedings advance through federal court channels. The company's corporate governance and disclosure practices remain under review as legal teams prepare corresponding procedural filings.
